Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases muscle mass regardless of DHT conversion blocking.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

Compound 4 is a promising treatment for hair loss with low toxicity.

Finasteride may help reduce opioid use.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Topical 5α-reductase inhibitor helps counteract hair loss and stabilize it.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Finasteride may help improve certain brain function issues linked to dopamine.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.